等待开盘 11-15 09:30:00 美东时间
-0.340
-3.64%
Exagen Inc. (Nasdaq: XGN), a leading autoimmune diagnostics provider, announced that its management will participate in two upcoming investor conferences: the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025, and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20, 2025. Exagen is committed to improving autoimmune disease management through innovative testing solutions, particularly i...
11-11 14:00
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
B. Riley Securities analyst Anderson Schock reiterates Exagen (NASDAQ:XGN) with a Buy and raises the price target from $15 to $18.
11-06 01:26
Exagen (($XGN)) has held its Q3 earnings call. Read on for the main highlights ...
11-05 09:06
Exagen (NASDAQ:XGN) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $67.487 million estimate.
11-04 21:02
Exagen (NASDAQ:XGN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.16) by 96.2 percent. This is a 10.71 percent decrease over losses of $(0.28) per share from the same
11-04 21:02
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
美参议院通过终止特朗普全面关税决议;美股三大指数期货走强,纳指期货涨逾1%;财报季多股绩后大涨,亚马逊盘前狂飙超12%,Reddit大涨超11%>>
10-31 20:26
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08